Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1707 in postmenopausal women with rheumatoid arthritis
NCT02884635Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of opigolix in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started Sep 2016; status: completed.
02
Drugs
opigolix
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02884635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02884635.